ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
Ascelia Pharma AB: ifrs:DilutedEarningsLossPerShare
One fact, its scope and the complete path back to the official record.
Reported value
-3{"amount": -3.24}- Entity
- Ascelia Pharma AB
- Metric
- ifrs:DilutedEarningsLossPerShare
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:5493002YR9VCJJPWYN08:2024-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:08:51.954826+02:00
Raw response SHA-256
3618fd33ae161b1e5e0c96fd474d2620…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.